Eton Pharmaceuticals Inc (ETON) — Cash Flow Reinvestment Rate
Eton Pharmaceuticals Inc (ETON) has a Cash Flow Reinvestment Rate of 0.01x as of March 2026, reinvesting $75.00K (capex $75.00K ) from operating cash flow of $7.41 Million. Check Eton Pharmaceuticals Inc (ETON) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Eton Pharmaceuticals Inc Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Eton Pharmaceuticals Inc across 4 annual periods. Explore Eton Pharmaceuticals Inc (ETON) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Eton Pharmaceuticals Inc (2022–2025)
Year-by-year capital reinvestment analysis for Eton Pharmaceuticals Inc. For live market cap and broader valuation context, see Eton Pharmaceuticals Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | $333.00K | $10.52 Million | $333.00K | ▼ -99.9% |
| 2024 | 41.32x | $40.04 Million | $969.00K | $26.00K | ▲ +18067.9% |
| 2023 | 0.23x | $1.55 Million | $6.82 Million | $775.00K | ▼ -80.3% |
| 2022 | 1.16x | $5.58 Million | $4.82 Million | $2.79 Million | — |